Rankings
▼
Calendar
DFTX Q1 2021 Earnings — Definium Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
DFTX
Definium Therapeutics, Inc.
$2B
Q1 2021 Earnings
Healthcare
Medical - Pharmaceuticals
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$14M
Net Income
-$14M
EPS (Diluted)
$-0.57
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$10M
Free Cash Flow
-$10M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$201M
Total Liabilities
$13M
Stockholders' Equity
$188M
Cash & Equivalents
$160M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$14M
-$4M
-226.8%
Net Income
-$14M
-$7M
-95.6%
← FY 2021
All Quarters
Q2 2021 →